This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Vifor Pharma Future Growth
Future criteria checks 1/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 13.3% |
| Revenue growth rate | 8.7% |
| Future return on equity | 13.5% |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
I Ran A Stock Scan For Earnings Growth And Vifor Pharma (VTX:VIFN) Passed With Ease
Dec 14
Is Vifor Pharma (VTX:VIFN) Using Too Much Debt?
Nov 24Here's Why We Think Vifor Pharma (VTX:VIFN) Is Well Worth Watching
Sep 03Is Vifor Pharma (VTX:VIFN) A Risky Investment?
Aug 17Do Investors Have Good Reason To Be Wary Of Vifor Pharma AG's (VTX:VIFN) 1.6% Dividend Yield?
May 10Vifor Pharma (VTX:VIFN) Seems To Use Debt Quite Sensibly
Mar 30Could The Vifor Pharma AG (VTX:VIFN) Ownership Structure Tell Us Something Useful?
Mar 10How Much Did Vifor Pharma's(VTX:VIFN) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 19Key Things To Consider Before Buying Vifor Pharma AG (VTX:VIFN) For Its Dividend
Jan 15
Vifor Pharma AG's (VTX:VIFN) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 24Is Vifor Pharma (VTX:VIFN) Using Too Much Debt?
Dec 01Getting In Cheap On Vifor Pharma AG (VTX:VIFN) Might Be Difficult
Jul 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 2,353 | N/A | N/A | N/A | 1 |
| 12/31/2023 | 2,189 | N/A | N/A | N/A | 1 |
| 12/31/2022 | 1,977 | N/A | N/A | N/A | 1 |
| 12/31/2021 | 1,812 | 147 | 414 | 527 | N/A |
| 6/30/2021 | 1,753 | 213 | 169 | 441 | N/A |
| 3/31/2021 | 1,757 | 176 | 119 | 432 | N/A |
| 12/31/2020 | 1,762 | 139 | 70 | 424 | N/A |
| 6/30/2020 | 1,709 | 93 | 301 | 500 | N/A |
| 3/31/2020 | 1,732 | 101 | 350 | 512 | N/A |
| 12/31/2019 | 1,754 | 108 | 399 | 525 | N/A |
| 9/30/2019 | 1,845 | 129 | 280 | 439 | N/A |
| 6/30/2019 | 1,784 | 100 | 169 | 353 | N/A |
| 3/31/2019 | 1,711 | 126 | 44 | 274 | N/A |
| 12/31/2018 | 1,639 | 152 | -82 | 194 | N/A |
| 9/30/2018 | 1,571 | 157 | -110 | 132 | N/A |
| 6/30/2018 | 1,504 | 162 | -139 | 70 | N/A |
| 3/31/2018 | 1,441 | 98 | -83 | 65 | N/A |
| 12/31/2017 | 1,378 | 34 | -28 | 60 | N/A |
| 9/30/2017 | 1,345 | 26 | -15 | 90 | N/A |
| 6/30/2017 | 1,312 | 18 | -2 | 120 | N/A |
| 3/31/2017 | 1,283 | 82 | 4 | 190 | N/A |
| 12/31/2016 | 1,254 | 147 | 10 | 259 | N/A |
| 9/30/2016 | 1,944 | 218 | 139 | 418 | N/A |
| 6/30/2016 | 2,635 | 290 | 267 | 577 | N/A |
| 3/31/2016 | 3,265 | 295 | 312 | 550 | N/A |
| 12/31/2015 | 3,896 | 301 | 358 | 522 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VIFN's forecast earnings growth is above the savings rate (-0.2%).
Earnings vs Market: Insufficient data to determine if VIFN's earnings are forecast to grow faster than the Swiss market
High Growth Earnings: Insufficient data to determine if VIFN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: VIFN's revenue (8.7% per year) is forecast to grow faster than the Swiss market (4.2% per year).
High Growth Revenue: VIFN's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VIFN's Return on Equity is forecast to be low in 3 years time (13.5%).